BSE Live
Dec 29, 16:01Prev. Close
1101.45
Open Price
1101.45
Bid Price (Qty.)
1136.30 (192)
Offer Price (Qty.)
1150.00 (4)
NSE Live
Prev. Close
Open Price
Bid Price (Qty.)
()
Offer Price (Qty.)
()
| Key Financial Ratios of Kwality Pharmaceuticals (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | 8.13 | 7.27 | 4.51 | 6.70 | 4.14 | |
| Diluted EPS (Rs.) | 8.13 | 7.27 | 4.51 | 6.70 | 4.14 | |
| Cash EPS (Rs.) | 12.36 | 10.22 | 7.26 | 11.20 | 7.14 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 44.62 | 36.49 | 29.22 | 49.42 | 43.46 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 45.39 | 37.26 | 29.99 | 50.96 | 45.06 | |
| Dividend / Share(Rs.) | 0.00 | 0.00 | 0.00 | 0.60 | 0.00 | |
| Revenue from Operations/Share (Rs.) | 133.66 | 159.16 | 131.87 | 183.73 | 151.50 | |
| PBDIT/Share (Rs.) | 17.38 | 15.58 | 12.13 | 19.38 | 11.90 | |
| PBIT/Share (Rs.) | 13.14 | 12.63 | 9.38 | 14.81 | 8.53 | |
| PBT/Share (Rs.) | 10.74 | 10.50 | 7.28 | 11.20 | 6.15 | |
| Net Profit/Share (Rs.) | 8.13 | 7.27 | 4.51 | 6.63 | 3.76 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | 13.00 | 9.78 | 9.20 | 10.54 | 7.85 | |
| PBIT Margin (%) | 9.83 | 7.93 | 7.11 | 8.06 | 5.62 | |
| PBT Margin (%) | 8.03 | 6.59 | 5.51 | 6.09 | 4.05 | |
| Net Profit Margin (%) | 6.07 | 4.56 | 3.41 | 3.60 | 2.48 | |
| Return on Networth / Equity (%) | 18.21 | 19.93 | 15.42 | 13.41 | 8.66 | |
| Return on Capital Employed (%) | 20.33 | 28.29 | 27.04 | 25.18 | 7.32 | |
| Return on Assets (%) | 6.26 | 7.05 | 4.78 | 4.77 | 3.60 | |
| Total Debt/Equity (X) | 0.68 | 0.68 | 0.84 | 0.71 | 0.56 | |
| Asset Turnover Ratio (%) | 102.97 | 154.36 | 140.06 | 132.33 | 145.19 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 1.31 | 1.22 | 1.20 | 1.26 | 1.43 | |
| Quick Ratio (X) | 0.98 | 1.04 | 0.96 | 0.93 | 1.10 | |
| Inventory Turnover Ratio (X) | 6.19 | 14.69 | 9.17 | 6.94 | 8.79 | |
| Dividend Payout Ratio (NP) (%) | 0.00 | 0.00 | 0.00 | 9.05 | 0.00 | |
| Dividend Payout Ratio (CP) (%) | 0.00 | 0.00 | 0.00 | 5.35 | 0.00 | |
| Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 90.95 | 0.00 | |
| Cash Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 94.65 | 0.00 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 56.78 | 63.90 | 66.95 | 65.67 | 0.00 | |
| EV/Net Operating Revenue (X) | 0.41 | 0.39 | 0.49 | 0.69 | 0.00 | |
| EV/EBITDA (X) | 3.15 | 3.95 | 5.32 | 6.53 | 0.00 | |
| MarketCap/Net Operating Revenue (X) | 0.19 | 0.23 | 0.31 | 0.52 | 0.00 | |
| Retention Ratios (%) | 0.00 | 0.00 | 0.00 | 90.94 | 0.00 | |
| Price/BV (X) | 0.57 | 1.02 | 1.40 | 1.94 | 0.00 | |
| Price/Net Operating Revenue | 0.19 | 0.23 | 0.31 | 0.52 | 0.00 | |
| Earnings Yield | 0.32 | 0.20 | 0.11 | 0.07 | 0.00 |
04.12.2025
Kwality Pharmac Consolidated September 2025 Net Sales at Rs 111.05 crore, up 23.34% Y-o-Y
27.11.2025
Kwality Pharmac Standalone September 2025 Net Sales at Rs 111.31 crore, up 23.63% Y-o-Y
08.09.2025
Kwality Pharmac Standalone June 2025 Net Sales at Rs 111.48 crore, up 39.21% Y-o-Y
20.05.2025
Kwality Pharmac Consolidated March 2025 Net Sales at Rs 115.68 crore, up 25.77% Y-o-Y
04.12.2025
Kwality Pharmac Consolidated September 2025 Net Sales at Rs 111.05 crore, up 23.34% Y-o-Y
27.11.2025
Kwality Pharmac Standalone September 2025 Net Sales at Rs 111.31 crore, up 23.63% Y-o-Y
08.09.2025
Kwality Pharmac Standalone June 2025 Net Sales at Rs 111.48 crore, up 39.21% Y-o-Y
20.05.2025
Kwality Pharmac Consolidated March 2025 Net Sales at Rs 115.68 crore, up 25.77% Y-o-Y